OncoMatch

OncoMatch/Clinical Trials/NCT07290491

Spiritual Care or Psychotherapy Versus Palliative Care Alone in Patients With Non-Curative Malignancies

Is NCT07290491 recruiting? Yes, currently enrolling (May 2026). This Phase 3 trial studies non-drug interventions for cancer.

Phase 3RecruitingThe Methodist Hospital Research InstituteNCT07290491Data as of May 2026

This phase III clinical trial will evaluate the impact on survival of adding chaplain-provided spiritual care or psychotherapy/meditation to standard-of-care (SOC) and palliative measures, plus chemotherapy if recommended, and comparing it with SOC and palliative measures, plus chemotherapy if recommended, in patients with non-curative malignancies. The Palliative Care Department at Houston Methodist Hospital provides essential services to patients diagnosed with advanced cancer by sharing information and resources about symptom management, pain treatment and planning for the future. It is also recognized that chaplaincy-based spiritual care of patients can be a valuable part of interdisciplinary interventions in oncology.

Check if I qualify

Extracted eligibility criteria

Disease stage

Metastatic disease required

Performance status

ECOG 0–3(Limited self-care)

Structured fields extracted by AI. May contain errors — verify against the official protocol.

US trial sites

  • Houston Methodist Neal Cancer Center · Houston, Texas

Showing up to 5 US sites. See all sites on ClinicalTrials.gov →

Could you qualify for this trial?

Enter your biomarker results to see how this trial's eligibility criteria match your specific cancer profile.

Check if I qualify